NASDAQ:SLGL - Sol Gel Technologies News Headlines

Sign in or create an account to add this stock to your watchlist.
Get Started
$6.69 +0.19 (+2.92 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$6.50
Today's Range$6.48 - $6.7742
52-Week Range$5.41 - $12.23
Volume2,608 shs
Average Volume10,669 shs
Market Capitalization$126.59 million
P/E Ratio-1.33
Dividend YieldN/A
BetaN/A

Headlines

Sol Gel Technologies (NASDAQ SLGL) News Headlines

Source:
DateHeadline
$50,000.00 in Sales Expected for Sol Gel Technologies Ltd (SLGL) This Quarter$50,000.00 in Sales Expected for Sol Gel Technologies Ltd (SLGL) This Quarter
www.americanbankingnews.com - February 18 at 3:46 AM
-$0.62 EPS Expected for Sol Gel Technologies Ltd (SLGL) This Quarter-$0.62 EPS Expected for Sol Gel Technologies Ltd (SLGL) This Quarter
www.americanbankingnews.com - February 16 at 3:18 PM
What Percentage Of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares Do Insiders Own?What Percentage Of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares Do Insiders Own?
finance.yahoo.com - February 6 at 4:01 PM
FDA OKs Perrigos generic Zovirax CreamFDA OKs Perrigo's generic Zovirax Cream
seekingalpha.com - February 6 at 11:51 AM
Sol-Gel Technologies Announces FDA Approval for Perrigo’s Generic Acyclovir Cream, 5%Sol-Gel Technologies Announces FDA Approval for Perrigo’s Generic Acyclovir Cream, 5%
finance.yahoo.com - February 6 at 11:51 AM
Sol Gel Technologies Ltd (SLGL) Given Consensus Recommendation of "Buy" by BrokeragesSol Gel Technologies Ltd (SLGL) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 1 at 1:32 AM
Brokerages Expect Sol Gel Technologies Ltd (SLGL) to Announce -$0.62 EPS Brokerages Expect Sol Gel Technologies Ltd (SLGL) to Announce -$0.62 EPS
www.americanbankingnews.com - January 24 at 7:12 PM
Sol-Gel Technologies Appoints John Vieira as U.S. Head of CommercializationSol-Gel Technologies Appoints John Vieira as U.S. Head of Commercialization
finance.yahoo.com - January 15 at 10:54 AM
Who Has Been Buying Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares?Who Has Been Buying Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Shares?
finance.yahoo.com - December 20 at 10:56 AM
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne VulgarisSol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne Vulgaris
finance.yahoo.com - December 17 at 11:01 AM
Sol-Gel Technologies Announces Participation in Upcoming Investor ConferenceSol-Gel Technologies Announces Participation in Upcoming Investor Conference
finance.yahoo.com - November 6 at 10:58 AM
Sol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic Product Candidate with PerrigoSol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic Product Candidate with Perrigo
finance.yahoo.com - November 2 at 11:17 AM
58 Stocks Moving In Thursdays Mid-Day Session58 Stocks Moving In Thursday's Mid-Day Session
www.msn.com - October 25 at 3:30 PM
Sol-Gel Technologies Ltd. (SLGL) Reports 50% Enrollment in Pivotal Phase III Epsolay Program for Treatment of Papulopustular RosaceaSol-Gel Technologies Ltd. (SLGL) Reports 50% Enrollment in Pivotal Phase III Epsolay Program for Treatment of Papulopustular Rosacea
www.streetinsider.com - September 26 at 10:55 AM
Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III Epsolay® Program for the Treatment of Papulopustular RosaceaSol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III Epsolay® Program for the Treatment of Papulopustular Rosacea
finance.yahoo.com - September 26 at 10:55 AM
How Financially Strong Is Sol-Gel Technologies Ltd (NASDAQ:SLGL)?How Financially Strong Is Sol-Gel Technologies Ltd (NASDAQ:SLGL)?
finance.yahoo.com - September 19 at 10:45 AM
Sol-Gel Technologies Names Jonathan B. Siegel to the Board of DirectorsSol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors
finance.yahoo.com - September 14 at 10:35 AM
Sol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne VulgarisSol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne Vulgaris
finance.yahoo.com - September 5 at 10:47 AM
6 Stocks Moving In Tuesdays After-Hours Session6 Stocks Moving In Tuesday's After-Hours Session
feeds.benzinga.com - September 4 at 6:31 PM
Sol-Gel flat on quarterly figuresSol-Gel flat on quarterly figures
www.baystreet.ca - August 8 at 10:46 AM
Sol-Gel Technologies Reports Second Quarter 2018 Financial ResultsSol-Gel Technologies Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 8 at 10:46 AM
Sol-Gel launches late-stage development of Epsolay for rosaceaSol-Gel launches late-stage development of Epsolay for rosacea
seekingalpha.com - June 19 at 9:54 AM
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular RosaceaSol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea
finance.yahoo.com - June 19 at 9:54 AM
Sol-Gel Technologies Announces Participation in Upcoming Investor ConferencesSol-Gel Technologies Announces Participation in Upcoming Investor Conferences
finance.yahoo.com - May 30 at 8:58 AM
Sol-Gel Technologies Reports First Quarter 2018 Financial ResultsSol-Gel Technologies Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 8:23 AM
How Do Analysts See Sol-Gel Technologies Ltd (NASDAQ:SLGL) Performing Over The Next Few Years?How Do Analysts See Sol-Gel Technologies Ltd (NASDAQ:SLGL) Performing Over The Next Few Years?
finance.yahoo.com - May 2 at 8:02 AM
Global Ceramic Coatings Market Report 2017-2025 Segmented by Application, Technology and Type - ResearchAndMarkets.comGlobal Ceramic Coatings Market Report 2017-2025 Segmented by Application, Technology and Type - ResearchAndMarkets.com
www.businesswire.com - March 28 at 3:19 PM
Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its WebsiteSol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website
finance.yahoo.com - March 27 at 6:52 AM
Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial ResultsSol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 26 at 3:18 PM
Acne Vulgaris Therapeutics Global Pipeline Analysis Report 2017Acne Vulgaris Therapeutics Global Pipeline Analysis Report 2017
www.bizjournals.com - March 16 at 6:32 AM
Dermira shares drop 66% after surprise acne clinical trial failureDermira shares drop 66% after surprise acne clinical trial failure
www.marketwatch.com - March 6 at 3:18 PM
JMP Securities Starts Sol Gel Technologies Ltd. (SLGL) at Market OutperformJMP Securities Starts Sol Gel Technologies Ltd. (SLGL) at Market Outperform
www.streetinsider.com - February 26 at 3:16 PM
Biotechs Take The Podium With The Years 3 Best IPOsBiotechs Take The Podium With The Year's 3 Best IPOs
seekingalpha.com - February 22 at 3:16 PM
Sol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual MeetingSol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting
finance.yahoo.com - February 16 at 5:18 AM
Sol-Gel Technologies Ltd. Announces Pricing of Initial Public OfferingSol-Gel Technologies Ltd. Announces Pricing of Initial Public Offering
finance.yahoo.com - February 14 at 4:39 PM
Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesSol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 14 at 4:39 PM
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: How to Invest in Growth Stocks
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel